WAIT for Q3 earnings confirmation before entering; entry on 10 EMA reclaim at 165 with volume confirmation

• MACD histogram improved from negative 2.44 to negative 0.23 over six sessions, but remains negative indicating downtrend bias
• Zero bullish divergence on RSI with price making lower lows
• No RSI divergence confirms continued downtrend rather than bottoming
• Current guidance for Q3 shows 4-6% revenue growth vs 13% growth last year, indicating deceleration
• Forward P/E of 13.2x could expand to 16x-18x on falling earnings if deceleration continues
• Phased entry proposal: half position at 2-3% of portfolio, second tranche at 155-158 (3-5% above wait price)
• 10 EMA reclaim at 165 with volume confirmation would be conservative entry signal
• Stop at 148 represents approximately 9% downside, but slippage can add 2-5% for real loss of 11-14%
• Bollinger lower band at 148 acts as magnet, not support wall, with next support at 130
• Institutional buying from Polaris and Emerald noted as two long-only funds, not tactical signal
• Polymarket recession probability priced at 8%
• Q3 earnings scheduled for early November as critical data point
• Potential 15-20% drawdown if Q3 earnings disappoint
• Meta Muse represents unresolved paradigm-shifting threat with zero visibility into outcomes
• 30-year yield at multi-decade highs causing ongoing multiple compression for long-duration assets like BKNG

→ vs aggressive: MACD histogram improvement signals slowing selling pressure, not emerging buying pressure; still negative histogram means trend bias remains down; 'the car is slowing down doesn't mean the crash is over'

→ vs aggressive: Phased entry math not favorable: 1-1.5% capital at risk now with inadequate compensation; waiting for 10 EMA reclaim at 165 sacrifices some delta but eliminates tail risk; 'we're not getting paid enough for the risk we're taking'

→ vs aggressive: Meta Muse threat requires zero visibility into outcomes; dismisses data absence as bullish incorrectly; conservative view is existential threat with no visibility demands capital preservation, not deployment into structurally impaired business model

→ vs aggressive: 'Cheap' P/E on decelerating earnings is value trap; base case assumes return to double-digit growth but current guidance is 4-6%; need Q3 print and Q4 guide confirmation before underwriting name

→ vs aggressive: Two funds adding (Polaris, Emerald) out of thousands is not tactical validation; long-only multi-year horizon funds can absorb drawdowns retail cannot; 'tactical execution has been failing for two months straight'

→ vs aggressive: 30-year yield at multi-decade highs not 'already priced in'; multiple compression is ongoing process in high-rate regime; BKNG is long-duration asset where macro pressure is ongoing, not behind us

→ vs aggressive: Stop at 148 not actually protective: fast markets add 2-5% slippage, and failure below 148 has no support until 130; 'stop' is actually entry point for bigger problem

→ vs aggressive: Entering before Q3 earnings is 'FOMO dressed up as analysis'; waiting two weeks for print, Muse commentary, and growth visibility has dramatically better expected value than entering on 'hope and momentum signals'

Structured entry: 1% initial position at $162-165 with stop at $148; add 1-1.5% on first trigger of either $155-158 retest with RSI below 30 or close above $170 reclaiming 10 EMA with volume; Q3 earnings decision point for full 2.5% exposure; 3-6 month time horizon.

• Forward P/E of 13.2x on 34% operating margins and 7.4% free cash flow yield; PEG of 0.89 is genuinely cheap
• Management accelerating buybacks to $7-8 billion run rate, retiring 6% of market cap in six months
• Two long-only shops (Polaris and Emerald) disclosed adds at 27% off 52-week high, establishing valuation floor
• MACD histogram still negative despite improvement; RSI at 33.55 approaching oversold but no bullish divergence or 30-cross confirmed
• Muse structural threat unresolved—lack of adoption data means neither threat nor safety is confirmed
• 30-year yield at multi-decade highs creates ongoing multiple compression pressure, not one-time event
• Entry at $170-175 after Q3 confirmation costs 5-8% more; MACD could already be positive and institutional accumulation could be complete
• 200 SMA at $182 intact as longer-term technical support; $130 scenario requires fundamental business-model break
• Q3 earnings in early November (approximately 5 weeks out) is the binary event decision point

→ vs aggressive: MACD histogram improvement is not a buy signal—it is still negative, and RSI has not crossed below 30 or shown bullish divergence; price is still making lower lows, so calling this discipline is front-running an unconfirmed reversal

→ vs aggressive: Muse risk dismissal is逻辑翻转—if no adoption data exists, threat is neither priced in nor priced out; a 5% single-day move on announcement is first take, not capitulation, leaving second leg down risk if metrics come in near Meta targets

→ vs aggressive: Macro 'already priced in' underestimates ongoing multiple compression—long-duration assets like BKNG face slow-growth high-rate regime without needing a recession trigger

→ vs conservative: 'Wait for confirmation' at $170-175 costs 5-8% more and risks missing the move entirely if MACD goes positive, 10 EMA is reclaimed, and institutional accumulation completes before entry

→ vs conservative: Dismissal of institutional buying as 'just two funds' ignores that Polaris and Emerald public client letters represent coordinated professional recognition of valuation dislocation, not anonymous flow noise

→ vs conservative: $148 stop failure risk to $130 overstated—200 SMA at $182 provides structural support, and $130 scenario requires fundamental deterioration beyond momentum flush